Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO)

Rennes University Hospital5 enrolled

Overview

The aim of the study is a better understanding of hemorrhagic events causes in patients with ECMO, prevent them and decrease the number of transfusion.

The most frequent complication during ECMO is hemorrhage especially as a curative anticoagulant treatment is necessary. The primary hemostasis is also affected with a von Willebrand disease and thrombopathy, well known but not studied by recent tests.The identification of primary haemostasis deficits with these tools would allow to supply them and decrease the morbi-mortality related to the transfusion.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Patients With ECMO

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient older than 18 years old * Patient with ECMO * Patient hospitalized in an intensive care unit at the University Hospital of Rennes Exclusion Criteria: * Known history for constitutional pathology of the primary haemostasis * Platelets \< 100000 / mm3 or hematocrit \< 28 % between H+12 and H+24

Locations (1)

CHU de Rennes

Rennes, France

Outcomes

Primary Outcomes

Evaluate primary hemostasis in patient with ECMO at University Hospital of Rennes

Time frame: Day 5

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.